Mutant IDH1 inhibitor

CAS NO.：1429180-08-4
Empirical Formula: C25H34N6O3
Molecular Weight: 466.58
Update Date: 2025-11-10 14:44:25

What is Mutant IDH1 inhibitor?

Description

Mutant IDH1 inhibitor is a potent mutant IDH1 R132H inhibitor with IC50 of < 72 nM.

in vitro

In Vitro:Mutant IDH1 inhibitor is a potent IDH1 R132H inhibitor, and used for the treatment of diseases or disorders associated with such mutant IDH proteins including, but not limited to, cell-proliferation disorders, such as cancer[1].

References

References:[1]. 3-Pyrimidin-4-yl-oxazolidin-2-ones as inhibitors of mutant IDH and their preparation. Patent WO 2013046136 A1 20130404

Properties of Mutant IDH1 inhibitor

storage temp.	Store at -20°C
solubility	DMSO: ≥ 34 mg/mL (72.87 mM)
form	Powder
color	White to light yellow

Safety information for Mutant IDH1 inhibitor

Computed Descriptors for Mutant IDH1 inhibitor

New Products

4-Bromo-2-chlorobenzonitrile 1-Chloro-4-Methyl-2-Nitrobenzene 1,3-Diethyl-1,3-Diphenylurea 3-(4-morpholinophenylamino)-5-amino-1H-pyrazole-4-carbonitrile Methyl 2-methylquinoline-6-carboxylate 2-((4-morpholinophenylamino) (methylthio) methylene) malononitrile Vitamin D3 vegan Progesterone Boldenone Clarithromycin Ethinyl Estradiol Stanozolol 2-Nitroacetophenone Methyl 2-oxo-2,3-dihydrobenzo[d]oxazole-7-carboxylate 4-(2-Aminoethyl)-7-hydroxy-2H-chromoen-2-one 3-Hydroxy-4-nitrobromobenzene 2-Ethyl-1,4-diaminobenzene 2-Ethylhexyl 4-aminobenzoate Thio Acetamide

Related products of tetrahydrofuran

CNX-1351

MS436

BMS 833923

BIX 02189

TG101209

CTS-1027

CCT 137690

PFK-015